The pharmaceutical distributor and health services company raises its guidance for the second time.

Cardinal Health reports strong Q2 results and raises fiscal 2026 outlook. Sales increased by 19%, beating estimates.

Healthcare distributor and services company Cardinal Health (NYSE:CAH) reported Q4 CY2025 results topping the market’s ...

Cardinal Health's second-quarter earnings might have been driven by Pharma and Specialty Solutions, as strong utilization and ...

Cardinal Health stock is being upgraded to a buy rating, from my prior hold rating last year, agreeing with the SA analyst consensus today. Bullish drivers include recent revenue/earnings growth, ...

Cardinal Health is scheduled to report fiscal second-quarter earnings before the market opens Thursday. Here is what you need to know. NET INCOME: The company, which distributes pharmaceutical and ...

DUBLIN, Ohio, June 4, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today the U.S. launch of its multi-parameter, single-patient use monitoring cable and lead wire system that enables the ...

Feb 1 (Reuters) - Cardinal Health (CAH.N), opens new tab lowered the full-year profit forecast for its medical segment on Thursday, taking the shine off the company's upbeat second-quarter results and ...

Cardinal Health (CAH) upgraded to Buy after a 100%+ run—see FY26 guidance, acquisitions, and nuclear medicine catalysts, plus ...

Narrow-moat Cardinal Health CAH reported better-than-expected results third-quarter results. Total sales were up 12.6% year over year driven by strong performance from its core distribution business.